Position in CHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$152,250
+$31,355 QoQ
Shares Held
108,750
+52.0% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. CHRS ranks #265 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in CHRS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $152,250 | 108,750 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $120,895 | 71,536 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $84,650 | 59,613 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $97,765 | 59,613 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $42,750 | 58,482 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $38,859 | 48,153 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $55,433 | 40,169 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $41,775 | 40,169 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $65,304 | 37,748 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $73,733 | 30,851 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $77,399 | 23,243 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $82,754 | 22,127 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $165,616 | 38,786 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $255,419 | 37,342 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $322,510 | 40,721 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $536,007 | 55,776 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $371,621 | 51,329 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $494,891 | 38,334 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $589,466 | 36,934 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $611,913 | 38,078 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $522,912 | 37,810 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $533,644 | 36,526 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,511,104 | 86,945 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,598,422 | 87,155 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $915,860 | 51,280 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,056,797 | 65,154 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||